GSA Capital Partners’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.04M | Buy |
|
|||||
|
2025
Q2 | $332K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.11M | Sell |
|
|||||
|
2023
Q4 | $1.94M | Buy |
|
|||||
|
2023
Q3 | $116K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $82K | Sell |
|
|||||
|
2022
Q4 | $250K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $67K | Sell |
|
|||||
|
2022
Q1 | $348K | Buy |
|
|||||
|
2021
Q4 | $274K | Buy |
|
|||||
|
2021
Q3 | $243K | Buy |
|
|||||
|
2021
Q2 | $220K | Sell |
|
|||||
|
2021
Q1 | $228K | Buy |
|
|||||
|
2020
Q4 | $167K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $204K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $731K | Sell |
|
|||||
|
2017
Q2 | $1.03M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $880K | Buy |
|
|||||
|
2016
Q2 | $639K | Buy |
|
|||||
|
2016
Q1 | $221K | Sell |
|
|||||
|
2015
Q4 | $241K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $703K | Buy |
|
|||||
|
2015
Q1 | $288K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $152K | Buy |
|